Giaccari, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 3.799
EU - Europa 3.425
AS - Asia 1.182
OC - Oceania 14
AF - Africa 12
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.444
Nazione #
US - Stati Uniti d'America 3.769
DE - Germania 695
PL - Polonia 624
SE - Svezia 508
IT - Italia 491
CN - Cina 430
SG - Singapore 329
UA - Ucraina 274
FR - Francia 201
IE - Irlanda 194
GB - Regno Unito 154
ID - Indonesia 120
IN - India 95
FI - Finlandia 86
TR - Turchia 84
RU - Federazione Russa 78
BE - Belgio 24
VN - Vietnam 21
AE - Emirati Arabi Uniti 20
CA - Canada 17
IR - Iran 17
JP - Giappone 17
HK - Hong Kong 16
NL - Olanda 16
CH - Svizzera 14
AU - Australia 13
AT - Austria 12
RO - Romania 11
ES - Italia 9
MX - Messico 8
MY - Malesia 8
BR - Brasile 6
GR - Grecia 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
IQ - Iraq 5
KR - Corea 5
PK - Pakistan 5
NG - Nigeria 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
BJ - Benin 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
HR - Croazia 2
IL - Israele 2
LT - Lituania 2
MD - Moldavia 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
AZ - Azerbaigian 1
BZ - Belize 1
CM - Camerun 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IS - Islanda 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 8.444
Città #
Chandler 708
Warsaw 542
Ashburn 303
Singapore 248
Fairfield 215
Dublin 191
Wilmington 182
Houston 159
San Mateo 156
Jacksonville 147
Rome 129
Jakarta 118
Seattle 110
Nanjing 106
Milan 101
New York 98
Woodbridge 91
Ann Arbor 84
Kraków 79
Izmir 73
Princeton 67
Boston 63
Dearborn 62
Cambridge 54
Moscow 53
Bremen 49
Beijing 46
Los Angeles 45
Redwood City 42
Hangzhou 41
Cattolica 37
Marseille 35
Mountain View 34
Helsinki 32
Chicago 31
Nanchang 31
Falls Church 29
London 28
Nürnberg 28
Boardman 26
Brussels 23
Lawrence 23
Lancaster 22
Redmond 21
Busto Arsizio 20
Norwalk 18
Kunming 17
Pune 17
San Diego 17
Shanghai 17
Sharjah 17
Andover 16
Augusta 16
Fremont 16
Jiaxing 16
Munich 16
Wayne 16
Dong Ket 15
Shenyang 15
Tianjin 15
Brescia 14
Hebei 13
Basking Ridge 12
Detroit 12
Blackpool 11
Tappahannock 11
Zhengzhou 11
Amsterdam 10
Kish 10
Vienna 10
Washington 10
Berlin 9
Changsha 9
Phoenix 9
Toronto 9
Bologna 8
Chiswick 8
Guangzhou 8
Hounslow 8
Lappeenranta 8
Manchester 8
Zurich 8
Kuala Lumpur 7
Palermo 7
Tokyo 7
University Park 7
Cincinnati 6
Frankfurt am Main 6
Santa Clara 6
Sydney 6
Barcelona 5
Changchun 5
Costa Mesa 5
Florence 5
Miami 5
Millbury 5
Paris 5
Prineville 5
Acerra 4
Brno 4
Totale 5.342
Nome #
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 310
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus. 305
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 274
Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial 264
Comment on: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 233
Sotagliflozin, the first dual SGLT inhibitor: Current outlook and perspectives 11 Medical and Health Sciences 1103 Clinical Sciences 214
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes 196
High-normal TSH values in obesity depends on adipose tissue rather than insulin resistance 171
In anorexia nervosa, even a small increase in abdominal fat is responsible for the appearance of insulin resistance 164
METABOLIC SYNDROME IN TRANSPLANT PATIENTS: AN UPDATING POINT OF VIEW 149
D-carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation 133
Removal of Duodenum Elicits GLP-1 Secretion 132
A Rare Case of Ectopic Adrenocorticotropic Hormone Syndrome Caused by a Metastatic Neuroendocrine Tumor of the Pancreas Detected by 68Ga-DOTANOC and 18F-FDG PET/CT 131
β-Cell Glucose Sensitivity Is Linked to Insulin/Glucagon Bihormonal Cells in Nondiabetic Humans. 130
The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach 127
Metabolic consequences of the occlusion of the main pancreatic duct with acrylic glue after pancreaticoduodenectomy 127
The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? 123
Hypovitaminosis D Is Associated with Liver Insulin Resistance in Obese Subjects 121
Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? 116
25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity 113
Metabolic syndrome in transplant patients: an academic or a health burden? 109
Single-fiber conduction velocity test allows earlier detection of abnormalities in diabetes 106
Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial 103
β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity 98
Will vitamin D reduce insulin resistance? Still a long way to go 97
High-normal TSH values in obesity: is it insulin resistance or adipose tissue's guilt? 97
Endocrine and Metabolic Insights from Pancreatic Surgery 97
β α-Cell glucose sensitivity is linked to insulin/glucagon bihormonal cells in nondiabetic humans 96
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study 94
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus 93
IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity 93
Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives 90
Increased B-cell workload modulates proinsulin-to-insulin ratio in humans 89
Vitamin D deficiency: a new risk factor for type 2 diabetes? 88
Insulin resistance alters islet morphology in nondiabetic humans 86
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes 85
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 83
Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes: Comment to Kayaniyil et al. 82
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: Evidence to date 80
Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports 76
Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment 75
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 75
Bile modulates secretion of incretins and insulin: a study on human extrahepatic cholestasis 72
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences 72
Postoperative hyperglycemia affects survival after gastrectomy for cancer: A single-center analysis using propensity score matching 71
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 71
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? 69
Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans 69
Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results 67
β-Adrenergic Responsive Induction of Insulin Resistance in Liver of Aging Rats 66
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 66
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. 65
Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis 64
Self-monitoring of blood glucose: guideline 1 application rather than utilization restrictions on testing strips has potential to reduce diabetic healthcare costs in Italy 63
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 63
The Interplay between Immune System and Microbiota in Diabetes 61
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation 60
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study 60
High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. 58
Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation 58
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience 58
A systematic comparison of protocols for recovery of high-quality rna from human islets extracted by laser capture microdissection 58
Peroxiredoxin 6, a novel player in the pathogenesis of diabetes 55
Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2 52
Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. 51
Nuclear export of FoxO1 is associated with ERK signaling in β-cells lacking insulin receptors 51
Evaluation of guidelines on diabetes medication 49
Genetic disruption of SOD1 gene causes glucose intolerance and impairs β-cell function 49
FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice 48
Self-management in patients with type 2 diabetes: Group-based versus individual education. A systematic review with meta-analysis of randomized trails 48
A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia 48
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 47
Management of diabetes in older adults 46
SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice 45
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 43
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 43
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 42
Transgenic mice with dominant negative PKC-theta in skeletal muscle: a new model of insulin resistance and obesity. 41
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population 41
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 41
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 40
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: the Italian Titration Approach Study (ITAS) 40
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report 39
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function 39
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes 38
Publish and perish 38
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials 38
Advancing Diabetes Research: a novel islet isolation method from living donors. 35
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010" 34
Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis 34
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes 33
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus 33
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features 31
Sodium-glucose co-transporter inhibitors: Medications that mimic fasting for cardiovascular prevention 31
Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS 31
Circulating 1,5-Anhydroglucitol as a Biomarker of ß-cell Mass Independent of a Diabetes Phenotype in Human Subjects 31
Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes 30
Expression of the two insulin receptor isoforms is not altered in the skeletal muscle and liver of diabetic rats. 30
Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2 28
Use and effectiveness of dapagliflozin in routine clinical practice. An Italian multicenter retrospective study 27
Totale 8.336
Categoria #
all - tutte 38.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020682 0 0 0 0 70 93 145 48 100 39 113 74
2020/2021913 49 80 84 90 130 62 91 28 95 46 117 41
2021/20221.100 102 69 50 76 78 36 65 199 40 71 129 185
2022/20231.995 230 233 161 324 115 241 58 173 255 48 83 74
2023/20241.206 56 290 47 52 63 157 113 82 26 62 95 163
2024/2025594 78 74 201 110 131 0 0 0 0 0 0 0
Totale 8.610